Completed OBSERVATIONAL NCT04658121

SARS-CoV-2/COVID-19 Prevalence Study

SARS-CoV-2 Prevalence Study

Sponsor: COVID-19 Prevention Network

Conditions COVID-19

Updated 7 times since 2021 Last updated: Sep 29, 2021 Started: Feb 4, 2021 Primary completion: Aug 12, 2021 Completion: Aug 12, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates COVID-19 and is currently completed. COVID-19 Prevention Network leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Nov 2021 — Dec 2021 [monthly]

Completed

Status: Active Not Recruiting → Completed
Sep 2021 — Nov 2021 [monthly]

Active Not Recruiting

Status: Enrolling By Invitation → Active Not Recruiting

▶ Show 2 earlier versions

Mar 2021 — Sep 2021 [monthly]

Enrolling By Invitation

Status: Not Yet Recruiting → Enrolling By Invitation
Jan 2021 — Mar 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

COVID-19 Prevention Network

Data source: COVID-19 Prevention Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Aurora, United States , Baltimore, United States , Chicago, United States , Cincinnati, United States , Houston, United States , Miami, United States , New Orleans, United States , New York, United States , Newark, United States and 3 more locations